Background Isolated cardiac sarcoidosis (iCS) is a poorly understood and under-recognised
entity. Previous research has postulated that those with iCS have worsened outcomes …

Background: In cardiac sarcoidosis (CS), the variability in initial presentation and outcome
poses problems in developing a management strategy. This study aimed to evaluate the …

A 53-year-old-male developed atrioventricular block in January 2001. A chest X-ray and
laboratory tests, including serum angiotensin converting enzyme, were normal. The patient …

Sarcoidosis is a multisystem disorder of unknown etiology, characterized by granulomatous
infiltration and the development of noncaseating granulomas in many organ systems …

During the period 1984-2005, eight patients aged 25-57 years were treated for cardiac
sarcoidosis. Diagnosis was obtained in three patients by endomyocardial biopsy, in three at …

Background Sarcoidosis is a multisystem inflammatory disease of unknown cause. Due to its
protean and nonspecific clinical manifestations, the optimal diagnostic and therapeutic …

The first described case of cardiac sarcoid was published by Bernstein and associates in
1929. While cardiac sarcoidosis is more common than previously recognized, the true …

The prognosis of sarcoidosis often considered as “benign” is significantly changed in the
presence of a cardiac localization. An in-depth interview, a clinical examination together with …

Background and objectives: A variety of markers, such as serum angiotensin‐converting
enzyme (sACE) and CXR have been used to evaluate the disease activity and progression …

Dyspnea and exercise intolerance are usually attributed to pulmonary disease in
sarcoidosis patients. However, cardiac involvement may also be responsible for these …